Helen Torley, PRESIDENT AND CEO at HALOZYME THERAPEUTICS, INC. (HALO), sold 30,000 shares at $42.69 ($1.3M) on 2023-07-26, disclosed to the SEC on 2023-07-27.
Scheduled sale ($1.3M) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.80 | 10,000 | $428K | 33.1% |
| 2 | $42.69 | 10,000 | $427K | 33.0% |
| 3 | $43.79 | 10,000 | $438K | 33.9% |
| Total | $43.09 avg | 30,000 | $1.3M | 100% |
| Filing → |
| HALO | SELL | 2026-08-19 | $6.3M | — | Filing → |
| HALO | SELL | 2026-07-09 | $153K | — | Filing → |
| HALO | SELL | 2026-06-03 | $3.4M | — | Filing → |